Award winning scientist and Managing Director of SYNthesis BioVentures Andrew Wilks tells James Willis how Australia's growing biotech sector is at risk of being stifled due to the government's CGT changes. 

Award winning scientist and Managing Director of SYNthesis BioVentures Andrew Wilks tells James Willis how Australia's growing biotech sector is at risk of being stifled due to the government's CGT changes.&nbsp;

Money News — the most respected business program on radio.

If you crave the latest insights into super & small business, interest rates & investment, and economics & e-commerce, then the team at Money News has everything you need to know.

Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing moneynews@2gb.com

Money News &mdash; the most respected business program on radio.
If you crave the latest insights into super &amp; small business, interest rates &amp; investment, and economics &amp; e-commerce, then the team at Money News has everything you need to know.
Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing <a href="mailto:moneynews@2gb.com">moneynews@2gb.com</a>

Money News

"Terrible outcome": Leading scientist says CGT change will kill innovation 🔬💸

https://api.omny.fm/orgs/88b564ea-a9a6-4751-910a-a5d800019396/clips/6d3babf8-8865-42f9-8ea1-b45700addac7/transcript